Edition:
United Kingdom

Cocrystal Pharma Inc (COCP.OQ)

COCP.OQ on NASDAQ Stock Exchange Capital Market

2.50USD
9:00pm BST
Change (% chg)

$-0.05 (-1.96%)
Prev Close
$2.55
Open
$2.57
Day's High
$2.57
Day's Low
$2.50
Volume
634
Avg. Vol
3,565
52-wk High
$5.50
52-wk Low
$1.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 5.08 0.098
FY 2018 Dec '18 0.00 -1.478
Sep '18 0.00 -0.062
Jun '18 0.00 -0.048
Mar '18 0.00 -0.064
FY 2017 Dec '17 0.00 0.212
Sep '17 0.00 -0.093
Jun '17 0.00 -0.041
Mar '17 0.00 -0.107
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Jun-19 1 -0.07 -0.07 -0.07 --
Quarter Ending Sep-19 1 -0.07 -0.07 -0.07 --
Year Ending Dec-19 1 -0.21 -0.21 -0.21 --
Year Ending Dec-20 1 -0.40 -0.40 -0.40 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.30 32.55
P/E High - Last 5 Yrs. -- 43.17 48.12
P/E Low - Last 5 Yrs. -- 22.71 23.41
Beta 1.93 0.86 0.87
Price to Sales (TTM) -- 6.59 8.44
Price to Book (MRQ) 1.74 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions 0.01 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.70
Payout Ratio(TTM) -- 42.19 39.61

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.43 13.46
Sales (TTM) vs TTM 1 Yr. Ago -100.00 6.61 8.04
Sales - 5 Yr. Growth Rate -- 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 69.87 45.66 47.72
EPS (TTM) vs TTM 1 Yr. Ago -80.95 -- --
EPS - 5 Yr. Growth Rate -- 9.90 10.46
Capital Spending - 5 Yr. Growth Rate -38.41 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) 2.74 2.87 2.98
LT Debt to Equity (MRQ) 0.00 8.86 11.32
Total Debt to Equity (MRQ) 0.00 12.87 16.01
Interest Coverage (TTM) -- 32.47 28.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 52.11 52.40
Gross Margin - 5 Yr. Avg. -- 49.67 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -196,820.59 17.26 12.41
Operating Margin (TTM) -- 13.53 5.67
Operating Margin - 5 Yr. Avg. -201,893.70 13.69 8.00
Pre-Tax Margin (TTM) -- 11.88 4.69
Pre-Tax Margin - 5 Yr. Avg. -208,399.09 14.09 8.28
Net Profit Margin (TTM) -- 8.79 1.42
Net Profit Margin - 5 Yr. Avg. -157,026.70 10.58 4.69
Effective Tax Rate (TTM) -- 22.13 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 928,432,432 820,086,371
Net Income/Employee (TTM) -3,954,722 105,142,926 92,829,218
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.41
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -41.33 10.98 10.65
Return on Assets - 5 Yr. Avg. -24.46 12.41 11.78
Return on Investment (TTM) -41.96 14.23 13.82
Return on Investment - 5 Yr. Avg. -25.93 16.18 15.32
Return on Equity (TTM) -52.95 15.46 15.24
Return on Equity - 5 Yr. Avg. -64.56 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -33.45 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cocrystal Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.06%
# of Holders: 30
Total Shares Held: 4,128,129
3 Mo. Net Change: 1,961,019
# New Positions: 5
# Closed Positions: 2
# Increased Positions: 12
# Reduced Positions: 8
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.